Oct 31, 2022 / 05:30AM GMT
Presentation
Oct 31, 2022 / 05:30AM GMT
=====================
Corporate Participants
=====================
* Hiroyuki Okuzawa
Daiichi Sankyo Company, Limited - Senior Executive Officer, Global Head of Corporate Planning & Management Div., CFO and Director
* Sunao Manabe
Daiichi Sankyo Company, Limited - President, Group CEO & Representative Director
* Wataru Takasaki
Daiichi Sankyo Company, Limited - Executive Officer, Head of R&D Division & VP of Precision Medicine Function
=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Naomi Kumagai
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., Research Division - Senior Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
*
Daiichi Sankyo Co Ltd
(FRA:D4S)
€
14.8
+0.22 (+1.52%)
Market Cap: 27.57 Bil
Enterprise Value: 26.19 Bil
PE Ratio: 19.88
PB Ratio: 3.05
GF Score: 80/100 Q2 2023 Daiichi Sankyo Co Ltd Earnings Presentation Transcript
Oct 31, 2022 / 05:30AM GMT
Release Date Price:
€32.28
(+2.93%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot